Posted Aug 28, 2026

[Remote] Clinical Trial Site Activation Lead

Apply Now

Note: The job is a remote job and is open to candidates in USA. Celea Therapeutics is a biotechnology company developing transformative treatments for serious respiratory diseases, including late-stage therapies for fibrotic lung diseases. The Clinical Trial Site Activation Lead will lead global clinical trial start-up activities from site feasibility and regulatory submissions through site initiation and enrollment readiness, while coordinating sponsors, CROs, sites, legal teams, and cross-functional stakeholders.


Responsibilities


Skills


Benefits


Company Overview

  • Celea Therapeutics develops therapies for idiopathic pulmonary fibrosis using its lead drug candidate deupirfenidone (LYT-100). It was founded in 2025, and is headquartered in Boston, Massachusetts, USA, with a workforce of 11-50 employees. Its website is https://www.celeatx.com.

  •